86 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 2 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABCA1ATP-binding cassette, sub-family A (ABC1), member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABCC8ATP-binding cassette, sub-family C (CFTR/MRP), member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
ADRB2Adrenoceptor beta 2, surfaceFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
AGTR1Angiotensin II receptor, type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Group enriched
ANO1Anoctamin 1, calcium activated chloride channelFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Expressed in all
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptideCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
ATP4AATPase, H+/K+ exchanging, alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
ATP6V1B2ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2FDA approved drug targets
Predicted intracellular proteins
Transporters
Expressed in all
AVPR1BArginine vasopressin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Not detected
AVPR2Arginine vasopressin receptor 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
CACNB2Calcium channel, voltage-dependent, beta 2 subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Mixed
CACNB3Calcium channel, voltage-dependent, beta 3 subunitFDA approved drug targets
Predicted intracellular proteins
Transporters
Mixed
CACNB4Calcium channel, voltage-dependent, beta 4 subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Tissue enhanced
CAMLGCalcium modulating ligandFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA4Cholinergic receptor, nicotinic, alpha 4 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Transporters
Mixed
CNR1Cannabinoid receptor 1 (brain)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CYSLTR1Cysteinyl leukotriene receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
FXYD2FXYD domain containing ion transport regulator 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GABRB2Gamma-aminobutyric acid (GABA) A receptor, beta 2FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GLRA1Glycine receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
GLRA2Glycine receptor, alpha 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
GLRBGlycine receptor, betaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GRIN1Glutamate receptor, ionotropic, N-methyl D-aspartate 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Transporters
Tissue enriched
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
KCNA2Potassium voltage-gated channel, shaker-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC3Potassium voltage-gated channel, Shaw-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCND2Potassium voltage-gated channel, Shal-related subfamily, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel, Shal-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH2Potassium voltage-gated channel, subfamily H (eag-related), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium inwardly-rectifying channel, subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium inwardly-rectifying channel, subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK3Potassium channel, subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced

Page of 2 | next »